Drug intelligence / Profile preview

PerioChip (Dexcel Pharma)

Development stage
Unknown
Lead developer
Dexcel Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

PerioChip is a biodegradable subgingival chip containing 2.5 mg of chlorhexidine gluconate, developed by Dexcel Pharma Technologies Ltd. for the treatment of inflammatory dental conditions, specifically peri-implantitis and periodontitis. The chip is composed of a hydrolyzed gelatin matrix that biodegrades naturally within 7 to 10 days after being inserted into the gum sulcus or periodontal pocket. During this period, it provides a sustained release of chlorhexidine gluconate, a broad-spectrum antimicrobial agent. Chlorhexidine acts by reacting with the microbial cell surface, destroying the integrity of the cell membrane, and causing cell death. In patients with peri-implantitis—an inflammation affecting the tissues and bone around a stable implant—PerioChip is used as an adjunct to mechanical subgingival debridement to improve clinical outcomes and reduce bone loss.

Brand names
PerioChip
Other names
Chlorhexidine gluconate chip

Beyond the preview

Go deeper on PerioChip (Dexcel Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PerioChip (Dexcel Pharma).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call